5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))

C76H50N14Pt2S2 — CID 157258701

IUPAC5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))
SMILESCn1ccnc1-c1cc(-c2ccccn2)[c-]c(-n2c3[c-]c(-c4nc5ccc(-c6nccn6C)cc5s4)ccc3c3ccccc32)c1.Cn1ccnc1-c1ccc2sc(-c3[c-]c4c(cc3)c3cc(-c5nccn5C)ccc3n4-c3[c-]c(-c4ccccn4)ccc3)nc2c1.[Pt+2].[Pt+2]
InChIInChI=1S/2C38H25N7S.2Pt/c1-43-18-16-40-36(43)25-10-13-33-30(21-25)29-12-9-27(38-42-32-22-26(11-14-35(32)46-38)37-41-17-19-44(37)2)23-34(29)45(33)28-7-5-6-24(20-28)31-8-3-4-15-39-31;1-43-17-15-40-36(43)24-11-13-32-35(23-24)46-38(42-32)25-10-12-30-29-7-3-4-9-33(29)45(34(30)22-25)28-20-26(31-8-5-6-14-39-31)19-27(21-28)37-41-16-18-44(37)2;;/h3-19,21-22H,1-2H3;3-19,21,23H,1-2H3;;/q2*-2;2*+2
InChIKeyCXLROJGXWFPSRZ-UHFFFAOYSA-N
MW1613.62 g/mol
LogP17.04
Rot. Bonds10

About 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))

5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)) (PubChem CID 157258701) has the molecular formula C76H50N14Pt2S2 and a molecular weight of 1613.62 g/mol. Its IUPAC name is 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)).

Molecular Properties

Compound Name5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))
PubChem CID157258701
Molecular FormulaC76H50N14Pt2S2
Molecular Weight1613.62 g/mol
Exact Mass1612.31
IUPAC Name5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))
SMILESCn1ccnc1-c1cc(-c2ccccn2)[c-]c(-n2c3[c-]c(-c4nc5ccc(-c6nccn6C)cc5s4)ccc3c3ccccc32)c1.Cn1ccnc1-c1ccc2sc(-c3[c-]c4c(cc3)c3cc(-c5nccn5C)ccc3n4-c3[c-]c(-c4ccccn4)ccc3)nc2c1.[Pt+2].[Pt+2]
InChIInChI=1S/2C38H25N7S.2Pt/c1-43-18-16-40-36(43)25-10-13-33-30(21-25)29-12-9-27(38-42-32-22-26(11-14-35(32)46-38)37-41-17-19-44(37)2)23-34(29)45(33)28-7-5-6-24(20-28)31-8-3-4-15-39-31;1-43-17-15-40-36(43)24-11-13-32-35(23-24)46-38(42-32)25-10-12-30-29-7-3-4-9-33(29)45(34(30)22-25)28-20-26(31-8-5-6-14-39-31)19-27(21-28)37-41-16-18-44(37)2;;/h3-19,21-22H,1-2H3;3-19,21,23H,1-2H3;;/q2*-2;2*+2
InChIKeyCXLROJGXWFPSRZ-UHFFFAOYSA-N
XLogP17.04
TPSA132.70 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds10
Heavy Atoms94
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001613.62
LogP ≤ 517.04
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))?
The IUPAC name of 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)) (CID 157258701) is 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)).
What is the SMILES notation for 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))?
The canonical SMILES for 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)) is Cn1ccnc1-c1cc(-c2ccccn2)[c-]c(-n2c3[c-]c(-c4nc5ccc(-c6nccn6C)cc5s4)ccc3c3ccccc32)c1.Cn1ccnc1-c1ccc2sc(-c3[c-]c4c(cc3)c3cc(-c5nccn5C)ccc3n4-c3[c-]c(-c4ccccn4)ccc3)nc2c1.[Pt+2].[Pt+2].
What is the InChIKey of 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))?
The InChIKey is CXLROJGXWFPSRZ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C38H25N7S.2Pt/c1-43-18-16-40-36(43)25-10-13-33-30(21-25)29-12-9-27(38-42-32-22-26(11-14-35(32)46-38)37-41-17-19-44(37)2)23-34(29)45(33)28-7-5-6-24(20-28)31-8-3-4-15-39-31;1-43-17-15-40-36(43)24-11-13-32-35(23-24)46-38(42-32)25-10-12-30-29-7-3-4-9-33(29)45(34(30)22-25)28-20-26(31-8-5-6-14-39-31)19-27(21-28)37-41-16-18-44(37)2;;/h3-19,21-22H,1-2H3;3-19,21,23H,1-2H3;;/q2*-2;2*+2.
What are the key properties of 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+))?
5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)) has a molecular weight of 1613.62 g/mol, XLogP of 17.04, 10 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(1-methylimidazol-2-yl)-2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;6-(1-methylimidazol-2-yl)-2-[9-[3-(1-methylimidazol-2-yl)-5-pyridin-2-ylbenzene-6-id-1-yl]-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;bis(platinum(2+)) is sourced from PubChem (CID 157258701), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).